Medical & Minimally Invasive Treatment of BPH
What are some of the treatments available for BPH?
Watchful waiting: Is recommended as an important option for men who have mild symptoms and do not find them particularly bothersome. It is the least invasive treatment and avoids the risks, inconvenience and costs of medical and surgical treatments. In some men, symptoms improve over time as long as there are no high-risk symptoms like urinary retention, recurrent urinary tract infection, recurrent blood in the urine, bladder stones, kidney failure or bladder diverticula.
Medical therapy: Today's most common method for controlling moderate symptoms of BPH. Several medications are available to control moderate symptoms of BPH.
Alpha blockers: These drugs, originally used to treat high blood pressure, work by relaxing the smooth muscle of the prostate and bladder neck to improve urine flow and reduce bladder outlet obstruction. Although alpha-blockers may relieve the symptoms of BPH, they do not reduce the size of the prostate. They are taken orally, once or twice a day, and work almost immediately. Commonly prescribed alpha-blockers include alfuzosin, terazosin, doxazosin, and tamsulosin. Side effects can include headaches, dizziness, light-headiness, fatigue, and difficulty breathing.
5-Alpha-Reductase Inhibitors: There are two medications available in this class, dutasteride, and finasteride, that work completely different than alpha blockers. In some men, dutasteride or finasteride can relieve BPH symptoms, increase urinary flow rate, and actually shrink the prostate. Like all medical therapy, these drugs must be used indefinitely to prevent recurrence of symptoms. This class of medications is best suited for men with relatively large prostate glands. It may take as long as six months to a year, however, to achieve maximum benefits from this drug. Side effects can include impotence, decreased libido, and reduced semen release during ejaculation.
What are some of the minimally invasive treatments available for BPH?
Prostatic stent (stenting): Anesthesia is not required for this procedure. The technology involves placing a spring-like contraption inside the prostatic part of the urethra to hold it open. There are many different kinds of stents but their overall use is limited. This is usually best suited for patients who have many medical problems or who are high-risk for surgery. Serious complications include urinary incontinence, dislodgement of stent position, stone formation on the stent with blockage, and difficulty removing the stent. Minor complications include urinary frequency and urgency, dribbling of urine, discomfort, and light bleeding. Patients with certain conditions are often advised against stent placement including those with strictures (narrowing) in the urethra, urinary infection, bladder stones, weak bladder and cancer, and patients who will be undergoing other procedures performed through the urethra soon after stent placement (e.g., treatment of kidney stones). Generally, prostatic stents are used for the same patients who would otherwise use an indwelling catheter or transurethral microwave thermotherapy (TUMT).
High-intensity focused ultrasound (HIFU): Anesthesia is usually required for this procedure. A special ultrasound probe is placed into the rectum near the prostate. Ultrasound waves heat the prostate up to very high temperatures, which causes destruction to the prostate tissue. The heated prostate tissue is destroyed and initially swells but then shrinks. The need for catheterization due to retention of urine and blood in the urine has been a problem postoperatively.
Holmium laser enucleation of prostate (HoLEP): After the patient receives anesthesia, the surgeon inserts an instrument called a resectoscope through the penis into the urethra. A visual lens and laser are passed through the hollow center of the instrument. The prostate tissue is vaporized using the holium: YAG laser. There is very little bleeding and recovery time is cut significantly. Typically, the patient has a catheter removed the next day and stays overnight in the hospital one day.
Transurethral resection of the prostate (TURP): Transurethral resection is the most common surgery for BPH. In the United States, approximately 150,000 people have TURPs performed each year. This can be done using electric current or with laser light. After the patient receives anesthesia, the surgeon inserts an instrument called a resectoscope through the tip of the penis into the urethra. The resectoscope contains a light, valves for controlling irrigating fluid, and an electrical loop that cuts tissue and seals blood vessels. The removed tissue pieces are carried by the irrigating fluid into the bladder and then flushed out and sent to a pathologist for examination under a microscope. At the end of the procedure, a catheter is placed in the bladder through the penis. The bladder is continuously irrigated with fluid through the catheter in order to monitor bleeding and prevent blood from clotting and obstructing the catheter. Since there are no surgical incisions with this procedure, patients normally stay in the hospital only one to two days. Depending on surgeon preference, the catheter may be removed while the patient is still in the hospital or the patient may be sent home with the catheter in place, attached to a leg bag for convenience, and removed several days later as an outpatient procedure.
Transurethral electroevaporation of the prostate (TUVP): After the patient receives anesthesia, the surgeon inserts an instrument called a resectoscope through the penis into the urethra. An electrode moves across the surface of the prostate and transmits current that vaporizes prostate tissue. The vaporizing effect penetrates below the surface area being treated so underlying blood vessels are coagulated and sealed. Bleeding and fluid absorption are minimal and patients can usually return home without a catheter after an overnight hospital stay.
Transurethral microwave thermotherapy of the prostate (TUMT): This is an office-based procedure performed with topical and oral pain medication and does not require anesthesia. Computer-regulated microwaves are sent through a catheter to heat portions of the prostate. A cooling system is required in some types for better tolerance. Traditionally, the best use of this procedure has been for patients who have too many medical problems for more invasive surgery or for patients who truly wish to avoid any type of anesthesia. Benefits are that there is no need for anesthesia and there is no blood loss or fluid absorption (these would be significant benefits in a person with a weak heart). Patients usually go home the same day. Many urologists have the technology available in their practice and results are pretty reliable regardless of who performs the procedure. The use of TUMT has been expanding to a broader patient population and there are several types of TUMT machines available.
Transurethral radiofrequency needle ablation of the prostate (TUNA): The procedure involves anesthesia and medications to make the patient sleepy. The technology involves heating of tissue using radiofrequency energy transmitted by needles inserted directly into the prostate. High-frequency radio waves heat the prostate up to very high temperatures. The heated prostate tissue is destroyed and initially swells but then shrinks. Most men require a catheter for a period of time after this procedure. Advantages in the use of TUNA include the limited anesthesia requirement, the ability to perform the procedure in an office setting, and avoidance of serious complications sometimes associated with other procedures.
Photoselective vaporization of the prostate (PVP): This is fast becoming a very popular procedure performed either in a well-equipped office or as an out-patient at the hospital. It uses a high-powered laser that vaporizes the obstructing prostate tissue with minimal bleeding or side effects. This procedure can serve to get men off of medical therapy. It is effectively replacing more invasive surgical treatment.
Catheterization: Placement of a catheter into the bladder will temporarily drain urine. Catheters can be placed intermittently every six to eight hours and clean intermittent or left in place for one to three months at a time (indwelling). Catheters can be placed either through the urethra or by making a small puncture into the bladder above the pubic bone (called a suprapubic tube). Infection is the biggest risk of having a catheter in place for long periods, as bacteria can stick to the surface of the catheter, making it difficult for the body's immune system or antibiotics to clear the organisms. Another risk is that after a few years there is a higher risk of bladder cancer due probably to the long-term irritation caused by the catheter sitting in the bladder. Catheterization, performed by the individual or a caregiver every six to eight hours, minimizes the risk of infection and cancer compared with an indwelling catheter. Catheters are most useful as a treatment of choice for temporary drainage while waiting for medication to start working, surgery to be scheduled, or clearance of infection. They also might be the most appropriate choice for a patient with multiple medical problems and a short life expectancy, where the risk and discomfort of surgery outweigh the risk of infection or cancer. Catheterization is the treatment of choice over medications or surgery for patients who have neurogenic bladder in addition to prostatic obstruction.
UroLift System: The UroLift treatment is a revolutionary, minimally invasive approach to treating an enlarged prostate, or BPH. The UroLift System lifts or holds the enlarged prostate tissue out of the way so it no longer blocks the urethra. There is no cutting, heating or removal of prostate tissue. Clinical data has shown that the UroLift treatment is safe and effective in relieving lower urinary tract symptoms due to BPH without compromising sexual function. The goal of the UroLift treatment is to relieve symptoms so you can get back to your life and resume your daily activities. Click here for more information on the UroLift System.
Rezum Water Vapor Therapy: Rezum Water Vapor Therapy is a non-surgical treatment that uses the natural energy stored in water vapor, or steam, to remove excess prostate tissue that is pressing on the urethra. Rezum Therapy is typically performed right in your urologists’s office, or at an outpatient surgery facility and completed in one short appointment. During each 9-second treatment, sterile water vapor is released throughout the targeted prostate tissue. When the steam contacts the prostate tissue, all the stored energy is released into the tissue. Over time, your body’s natural healing response absorbs the treated tissue, shrinking the prostate. With the extra tissue removed, the urethra opens, reducing BPH symptoms. Rezum has helped many patients get off their BPH medications while providing long-lasting relief from BPH. Clinical data published in 2020 shows that 95.6% of Rezum patients did not need any further surgical intervention at 5 years while also preserving sexual function. Click here to learn more about Rezum Water Vapor Therapy. Click here for more information on Rezum Water Vapor Therapy.
Aquablation Therapy: Aquablation therapy is a new type of surgical treatment for benign prostatic hyperplasia (BPH). At UroPartners, we are proud to be among the first in the Midwest to offer this advanced, minimally invasive treatment. We are excited to offer Aquablation therapy through Dr. Lin at our N Saint Clair St. location because we believe in helping men suffering from BPH to get their life back and feel like themselves again. We know choosing a treatment option can be overwhelming, as it often forces men to compromise in some way. This could mean not responding well to medication, or choosing a treatment that only provides limited relief, that may have a long recovery time, or that may even cause issues with sexual function. Aquablation therapy is a one-of-a-kind procedure that aims to minimize this compromise. Click here for more information on Aquablation Therapy.
Frequently Asked Questions:
Is BPH a rare condition?
No, it is very common. It will affect approximately 50 percent of men between the ages of 51 and 60 and up to 90 percent of men over the age of 80.
Does BPH lead to prostate cancer?
No, BPH is not cancer and cannot lead to cancer, although both conditions can exist together.There are usually no symptoms during the early stages of prostate cancer; so yearly physical examinations and PSA testing are highly recommended.
Which type of drugs are the best?
To date, there are not enough research data to predict who will respond to medical therapy or which drug will be better for an individual patient.
How do I know if oral medications are the best treatment for me?
If you are diagnosed with BPH, you should discuss all treatment options with your urologist. Together, you can decide whether medication or surgical treatment is best for you.
If I am 65 and healthy with mild urinary symptoms, which is the best treatment for me?
As long as your symptoms are mild, your quality of life is not very affected and you do not have any compelling reason to have invasive surgical therapy right away, you can start with watchful waiting or the medical therapies. If those options are ineffective or your symptoms worsen over time, then minimally invasive therapy or surgical treatment may be the answer.